Advanced search

Xu Yi founded Bilibili, Inc. and Shanghai Hode Information Technology Co. Ltd. Presently, he is President & Director at Bilibili, Inc. Xu Yi is also on the board of Chaodian, Inc. Mr. Yi received an undergraduate degree from Beijing University of Posts & Telecommunications.

Xu Yi Hu worked as the Chief Financial Officer at Beijing Zodi Investment Co., Ltd.
from 2017 to 2019.

Xu Yizhou currently works at Industrial Securities Co. Ltd.
(Broker), as Research Analyst.

Xu Ying Wang has worked as a Member-Supervisory Board at Shenzhen Gas Corp.
Ltd.
since 2017.

Xu Yi Zhong is currently the Chief Financial Officer & Executive Director at Cheerwin Group Ltd.
He is also a Director at Guangzhou Cheerwin Biotechnology Co. Ltd.
and Anfu Cheerwin Rihua Co., Ltd.
Previously, he worked at Liby Group Co ltd as the Deputy Director-Taxation from 2003 to 2018.
Mr. Zhong graduated from Sun Yat-Sen University with a graduate degree in 2010 and from Guangdong University of Finance & Economics with an undergraduate degree in 2003.

Xu Ying Long has worked as an Independent Director at Hubei KAIT Automotive Electronic & Electrical Systems Co. Ltd.
since 2018.

Xu Ying Lang is currently a Member-Supervisory Board at Jinzhou Port Co., Ltd.
She completed her undergraduate degree from Liaoning University.

Xu Ying Zhang worked as a Member-Supervisory Board at Xinjiang Xintai Natural Gas Co., Ltd.

Xu Yang Xu is the Chairman of Chengdu Bright Eye Hospital Co., Ltd.

Xu Dong Xu occupies the position of Chairman & General Manager at Ningbo Xusheng Auto Technology Co., Ltd.

Presently, Yi Lin is Chairman-Supervisory Board at Fujian Anjoy Foods Co. Ltd.

Currently, Yi Feng occupies the position of Director & Deputy General Manager at Sangfor Technologies, Inc. Yi Feng received an undergraduate degree from the University of Science & Technology of China.

Yi Sun occupies the position of Chairman for Zhefu Holding Group Co., Ltd., Chairman for Zhejiang Gerui Energy Power Technology Co., Ltd. and Chairman at Zhejiang Shenlian Environmental Protection Group Co., Ltd. (both are subsidiaries of Zhefu Holding Group Co., Ltd.) and General Manager & Executive Director at Zhejiang Jingfeng Environmental Protection Tech Co., Ltd.

Ms. Yi Larson is an Independent Director at Olema Pharmaceuticals, Inc. She is on the Board of Directors at Olema Pharmaceuticals, Inc. and Rayzebio, Inc. Ms. Larson was previously employed as a Chief Financial Officer & Executive Vice President by Turning Point Therapeutics, Inc. She received her undergraduate degree from The Wharton School of the University of Pennsylvania, a graduate degree from Massachusetts Institute of Technology and an MBA from The Wharton School of the University of Pennsylvania.

Currently, Yi Gao holds the position of Chairman & Chief Executive Officer at Yifeng Pharmacy Chain Co., Ltd. and Chairman for Shanghai Shanghong Drugstore Chain Co., Ltd. Mr. Gao is also on the board of Jiangsu Yifeng Pharmacy Chain Co., Ltd. and Shanghai Yifeng Pharmacy Chain Co., Ltd.

Yi Ding is currently serving as an Independent Director at Hua Xia Bank Co., Ltd., Tongwei Co., Ltd., and S.F.
Holding Co., Ltd.
She previously served as Chairman at Huaneng Capital Services Corp.
Ltd.
and China Great Wall Securities Co., Ltd.
She also served as an Independent Director at Hua Xia Bank Co., Ltd., Huatai Asset Management Co., Ltd., and Yuanshi Advanced Materials Co. Ltd.
Dr. Ding completed her undergraduate degree from Renmin University of China.

Yi Huang founded Zhongsheng Group Holdings Ltd. Mr. Huang is Chairman at this company. Mr. Huang is also on the board of Light Yield Ltd. and Blue Natural Development Ltd. In his past career he held the position of Director & General Manager at China Resources Machinery Co. Ltd. Yi Huang received an undergraduate degree from Xiamen University.

Currently, Yi Zhao occupies the position of Chairman & General Manager at Hangzhou Chang Chuan Technology Co., Ltd. and Chairman & General Manager for Hangzhou Changxin Investment Management Co., Ltd. (a subsidiary of Hangzhou Chang Chuan Technology Co., Ltd.).

Presently, Yi Tang occupies the position of Chief Financial Officer for Fujian Anjoy Foods Co. Ltd.

Currently, Yi Zhang is Chairman of Liaoning Port Co., Ltd. Dr. Zhang received an undergraduate degree and a doctorate from Wuhan University of Technology and a graduate degree from Party School of the Central Committee of CPC.

Yi Weng is currently the Chairman-Supervisory Board at COSCO SHIPPING Energy Transportation Co., Ltd.
and Chairman-Supervisory Board at Cosco Shipping Bulk Co. Ltd.
He also holds the position of Safety Director & GM-Safety Supervision at China COSCO Shipping Corp., Ltd.
and Director at Cosco Shipping Ferry Co. Ltd.
In the past, he served as Chairman-Supervisory Board at Cosco Ocean Shipping Bulk Cargo Transport Co., Ltd., Deputy Director-Shipping Department at China Shipping (Group) Co., Ltd., and General Manager at Zhuhai New Century Shipping Co. Ltd.

Yi Zhang is currently the Co-Vice Chairman at Jiayuan International Group Ltd.
Prior to this, he held positions as the Chief Executive Officer at HNA Hotels & Resorts Holding Group Co., Ltd., the Chief Executive Officer & Executive Director at Grandland Holdings Group Co., Ltd., and the General Manager & Financial Controller at Haikou Meilan International Airport Co., Ltd.
He also served as a Project Manager-Hainan Airlines at HNA Group Co., Ltd.
and as the GM-Planning & Finance, Financial Controller at Hainan Airlines Holding Co., Ltd.
Mr. Zhang received his undergraduate degree from Wuhan University in 1995 and his MBA from Cheung Kong Graduate School of Business in 2006.

Founder of Hithink RoyalFlush Information Network Co., Ltd., Zheng Yi is Chairman & General Manager at this company and Chairman & General Manager of Zhejiang Flush Network Technology Co. Ltd. and Chairman & General Manager of Hangzhou Hexin Software Technology Co., Ltd. (both are subsidiaries of Hithink RoyalFlush Information Network Co., Ltd.). Zheng Yi received a graduate degree from Dalian University of Technology and an undergraduate degree from Zhejiang University.

Currently, Yi Li occupies the position of Chief Executive Officer & Executive Director at Sino Biopharmaceutical Ltd. He previously was Assistant at UBS Securities Co. Ltd. Mr. Li received an MBA from The Wharton School of the University of Pennsylvania, an undergraduate degree from China University of Political Science & Law and an undergraduate degree from Beijing Sport University.

Yuan J.
Xu is an Independent Director at Fate Therapeutics, Xilio Therapeutics, and Akero Therapeutics.
Previously, Xu served as the Chief Executive Officer & Director at Legend Biotech Corp., General Manager & Vice President-Biologics at Gilead Sciences, Senior Vice President at Merck & Co., and Vice President at Novartis AG.
Xu holds a doctorate from the University of Maryland and an undergraduate degree from Nanjing University.

Currently, Gang Xu holds the position of President, General Manager & Director at China Greatwall Technology Group Co., Ltd. and Chief Executive Officer & Director at Wuhan Zhongyuan Electronics Group Co., Ltd. (a subsidiary of China Greatwall Technology Group Co., Ltd.).

Mr. Xu Tao is a Chief Financial Officer at Beike Zhaofang (Beijing) Technology Co., Ltd. and a Chief Financial Officer at KE Holdings, Inc. Mr. Tao was previously employed as a Chief Financial Officer by Dimension Data Information Technology (Beijing) Co. Ltd., a Financial Director by Sun Microsystems (China) Co., Ltd., a Chief Financial Officer by Lucent Technologies Investment Co., Ltd., and a Financial Manager by Beijing Sohu Internet Information Service Co. Ltd. He received his undergraduate degree from Capital University of Economics & Business and a graduate degree from The University of New South Wales.

Hong Xu is currently the Director at Meinian Onehealth Healthcare (Group) Co., Ltd.
and the Chief Financial Officer at Alibaba Group Holding Ltd.
He is also a Member of The Chinese Institute of Certified Public Accountants and a Member-Supervisory Board at Ant Group Co., Ltd.
In the past, Mr. Xu served as a Non-Executive Director at Lianhua Supermarket Holdings Co., Ltd., Alibaba Health Information Technology Ltd., Meinian Onehealth Healthcare Holdings Co., Ltd., Alibaba Pictures Group Ltd., and Sun Art Retail Group Ltd.
He was also a Non-Independent Director at Suning.com Co., Ltd.
and Red Star Macalline Group Co., Ltd.
Additionally, he held positions as a Director at DSM Grup Danismanlik Iletisim ve Satis Ticaret AS and Concord Investment (China) Co., Ltd.
Furthermore, Mr. Xu worked as a Partner at PricewaterhouseCoopers China Ltd.Mr. Xu completed his undergraduate degree at Fudan University in 1996.

Song Xu is currently the Vice Chairman & Chief Executive Officer at China Merchants Port Holdings Co., Ltd.
and China Merchants Port Group Co., Ltd.
He also holds positions as Deputy Chairman at Dalian China Oil Dock Management Co. Ltd., Chairman at Dalian Ocean Shipping Tally Co., Ltd., Deputy Chairman at Dalian Port PetroChina International Terminal Co., Ltd., Chairman at Zhanjiang Port Group Co. Ltd., Chairman at DCT Logistics Co., Ltd., Director at Dalian International Logistics Park Development Co., Ltd., Director at Dalian Port Container Development Co., Ltd., Director at Dalian Port Bulk Cargo Logistics Center Co., Ltd., and Director at Da-In Ferry Co., Ltd.
Previously, Dr. Xu served as Chairman at Odfjell Terminals (Dalian) Ltd., Non-Executive Director at Liaoning Port Co., Ltd., General Manager & Director at Dalian Port Corp.
Ltd., Deputy General Manager at Dalian Portnet Co. Ltd., General Manager at Dalian Port Container Co., Ltd., General Manager at Dalian Port Jifa Logistics Co., Ltd., Deputy General Manager at Liaoning Port Group Co., Ltd., General Manager at Dalian Jifa Logistics Co., Ltd., and General Manager at Dalian Port North Yellow Sea Port Cooperation Management Co.Dr. Xu's education includes an undergraduate degree from Huazhong University of Science & Technology, a graduate degree from Coventry University, a doctorate degree from Dalian Maritime University, and an MBA from Dongbei University of Finance & Economics.

Yang Xu currently works at GameStop Corp., as Independent Director from 2021 and Straumann Holding AG, as Chief Financial Officer from 2023.
Ms. Xu also formerly worked at The Kraft Heinz Co., as Treasurer, SVP & Global Head-Corporate Development from 2022 to 2023.
Ms. Xu received her undergraduate degree from Wuhan University, Masters Business Admin degree from École des Hautes Études Commerciales de Paris, and Masters Business Admin degree from London Business School.

Jun Xu currently works at Zhejiang Leapmotor Technology Co., Ltd., as Chief Operating Officer & Senior Vice President from 2023.

Xu Liu is currently the President, Executive Director, and Executive VP at Shengjing Bank Co., Ltd.

Bin Xu holds the position of Vice Chairman & General Manager at HBIS Co., Ltd.

Currently, Jian Xu is Chairman at Jinzhou Port Co., Ltd., Chairman for Dalian Port Harbour Construction Superintendece & Consulting and Chairman for Dalian Port Design & Research Institute Co. Ltd. He is also on the board of Yingkou Port Group Corp., Dalian Port Corp. Ltd. and Dalian Port PetroChina International Terminal Co., Ltd. and Deputy President at China Water Transportation Construction Association. Mr. Xu received an undergraduate degree from Tianjing University.

Hang Xu founded Mindray Medical International Ltd. Presently, Mr. Xu is currently Co-Chairman at this company. He is also on the board of Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (former Chairman). He received an undergraduate degree and a graduate degree from Tsinghua University and an MBA from China Europe International Business School.

Jin Xu is Chairman & General Manager of Anhui Kouzi Distillery Co., Ltd.

Currently, Elaine Xu holds the position of Manager-Operations & Management Centre at SITC International Holdings Co., Ltd.

Xu Wang is Chief Financial Officer, Director & Deputy GM at Suzhou Dongshan Precision Manufacturing Co., Ltd. Xu Wang is also on the board of Multi-Fineline Electronix, Inc.

Ming Xu is on the board of Yunnan Energy New Material Co., Ltd.

Bo Xu holds the position of Chief Financial Officer at Zhejiang Supor Co., Ltd. Mr. Xu received an undergraduate degree from Central University of Finance & Economics.

Currently, Ning Xu holds the position of Executive VP & Head-Clinical Operations at Zai Lab Ltd. Dr. Xu is also on the board of Drug Information Association. In his past career Dr. Xu held the position of Vice President & Head-Clinical Development Service at Covance Pharmaceutical Research & Development Beijing Co. Ltd. Ning Xu received an undergraduate degree from Peking Union Medical College and a graduate degree from the University of Illinois.

Ms. Ran Xu, CPA, is a Chief Financial Officer at JD.com, Inc. She is on the Board of Directors at JD Health International, Inc., Jingdong Digits Technology Holding Co. Ltd., Dada Nexus Ltd. and JD Logistics, Inc. Ms. Xu was previously employed as an Audit Partner by PricewaterhouseCoopers (Beijing), an Audit Partner by PricewaterhouseCoopers LLP, and an Audit Partner by PricewaterhouseCoopers Zhong Tian LLP. She received her undergraduate degree from Peking University.

Presently, Zhoujin Xu holds the position of Chief Financial Officer & Executive Vice President of Yonyou Network Technology Co., Ltd. He is also on the board of Chanjet Information Technology Co., Ltd. Mr. Xu received an undergraduate degree from Central University of Finance & Economics.

Yi Xiao is currently working as the Deputy Director of the Finance Department at China Petrochemical Corp.
Prior to this, he worked as the Chief Financial Officer at Sinopec Oilfield Service Corp from 2019 to 2021.
He also worked as the Head of the Finance Division at China Petroleum & Chemical Corp.
and as a Finance Manager at SINOPEC Zhanjiang Dongxing Petrochemical Co., Ltd.

Yi Zhang is currently the Chairman at Cinda International Holdings Ltd.
and a Director at Cinda Futures Co., Ltd.
He also holds the position of CFO and GM-Planning & Finance at Cinda Securities Co., Ltd.
Mr. Zhang previously served as the Chairman at Shanghai Baichuan Jinzhi Intelligent Technology Co. Ltd.
and as the General Manager & Executive Director at Cinda Innovation Investment Co., Ltd.
He was also the Deputy General Manager at Sinodata Co., Ltd.
and Vice President of the Risk Management Department at China International Capital Corp.
Ltd.
Mr. Zhang completed his undergraduate degree at Tsinghua University.

Yulong Yi has held positions as Chairman, President, CEO, CFO, Secretary, and Director in companies such as Gushen, Inc. and Dyckmanst Ltd.
Currently, Mr. Yi holds positions in Gushen, Inc. and Dyckmanst Ltd.
as their Chairman, President, CEO, CFO, Secretary, and Director.

Yi Sun is a professional with current and former positions.
Currently, he is a Non-Executive Director at Black Spade Asia Acquisition Co. His former positions include Deputy Director-Administration at Everbright Securities Co., Ltd., Executive Vice President at Federation of Hong Kong Jiangsu Youth Ltd., and Vice President at Chinese FI Finance & Treasury Association of Hong Kong Ltd.
Dr. Sun has an educational background from Fudan University, where he received his undergraduate, graduate, and doctorate degrees in 1993, 1996, and 2006, respectively.

Yi Li is currently working as the Finance Director & Chief Financial Officer at Kingsoft Corp.
Ltd.
Additionally, Ms. Li is a Member of the Association of Chartered Accountants.

Yi Liang currently works at Everbright Securities Co., Ltd., as Chairman-Supervisory Board from 2022.
Mr. Liang received his graduate degree from Renmin University of China.

Yi Xie holds the position of Chairman for Tongwei Co., Ltd. He received an MBA from Imperial College London.

Yi Wang holds the position of General Manager, CFO & Director at Topchoice Medical Corp. She is also on the board of Zhejiang Topchoice Dental Hospital Invt Mgmt Group Co., Ltd.

Kathy Yi is on the board of Sangamo Therapeutics UK Ltd. and Theseus Pharmaceuticals, Inc. In the past Ms. Yi held the position of CFO, Secretary, Principal Accounting Officer & EVP at Sangamo Therapeutics, Inc., Chief Financial Officer at Cerevel Therapeutics Holdings, Inc., Director-Finance & Corporate Development at Life Technologies Corp. and Head-Finance, Inhalation Technical R&D at Novartis Pharmaceuticals Corp. She received an undergraduate degree from the University of California, Berkeley and an MBA from Columbia Business School.

Yi Zhang occupies the position of Chief Financial Officer & Deputy General Manager at Beijing Tiantan Biological Products Corp. Ltd. Yi Zhang is also on the board of Changchun Keygen Biological Products Co. Ltd.

Yi Zhang is Chief Operational Officer & General Manager at China Merchants Port Group Co., Ltd. In the past he occupied the position of Deputy General Manager for China Merchants Port Holdings Co., Ltd. and Secretary at Zhanjiang Port Group Co. Ltd. He received a doctorate from Wuhan University of Technology and an undergraduate degree from Wuhan Institute of Technology.

Hao Yi is Chief Risk Officer at Sinolink Securities Co., Ltd.

Presently, Yi Zhou holds the position of General Manager & Director at Shenzhen Chengxin Lithium Group Co., Ltd. Mr. Zhou is also on the board of Jiangxi Wanhong High-Tech Materials Co., Ltd. Mr. Zhou received an undergraduate degree from Chongqing University and an MBA from Southwestern University of Finance & Economics.

Presently, Yi Liu is Vice President of Shanghai Fosun Pharmaceutical (Group) Co., Ltd. and Chairman for Sisram Medical Ltd. and Vice President of Fosun Pharma Industrial Pte Ltd. (both are subsidiaries of Shanghai Fosun Pharmaceutical (Group) Co., Ltd.). He is also on the board of Alma Lasers Ltd. and Vice President of Fosun Pharma Industrial Pte Ltd. Yi Liu previously held the position of Head at Beijing Medical Equipment Laboratory. He received an undergraduate degree from Beijing Institute of Technology and a graduate degree from Peking University.

Currently, Yi Ding occupies the position of Chairman of Magang Group Finance Co., Ltd., Chairman at Maanshan Iron & Steel Co., Ltd. and General Manager & Director at Magang (Group) Holding Co., Ltd. In his past career Dr. Ding held the position of Chairman for Maanshan Boc-Ma Steel Gases Co. Ltd. and Deputy General Manager of Maanshan Iron & Steel Co., Ltd.

Yi Zhou is a Chinese businessperson who has been at the head of 10 different companies and currently occupies the position of Chairman of Jiangsu Emerging Industry Investment Co. Ltd., Chairman of Huatai Ruilian Funds Management Co. Ltd., Chairman at Huatai Junxin Fund Investment Management Co. Ltd., Chairman for Beijing Huatai Tongxin Investment Fund Management Co. Ltd. and President, CEO & Executive Director at Huatai Securities Co., Ltd., Chairman for Huatai Zijin Investment Co., Ltd., Chairman & General Manager of Huatai Securities Co., Ltd. (Broker) and Chairman for Huatai Ruitong Investment Management Co. Ltd. (which are all subsidiaries of Huatai Securities Co., Ltd.). He is also on the board of AssetMark Financial Holdings, Inc. In the past he occupied the position of Chief Executive Officer & Director at The Hartcourt Cos., Inc., Deputy General Manager for Shanghai Beier Fortune Communications Co. Ltd. and Chief Executive Officer at Huatai Securities (Shanghai) Asset Management Co., Ltd. He received an undergraduate degree from Hunan University, an MBA from China Europe International Business School and an undergraduate degree from Nanjing University of Posts & Telecommunications.

Yi Hyon Paik is on the board of Orion Engineered Carbons SA and Business Group Director at Rohm & Haas Electronic Materials LLC. He previously occupied the position of President & Chief Strategy Officer at Samsung SDI Co., Ltd. and Head-Electronic Materials Business at Cheil Industries, Inc. (Gumi) (a subsidiary of Samsung SDI Co., Ltd.), Chairman & Chief Executive Officer at Shipley Far East Ltd., Head-Electronic Materials at The Dow Chemical Co., Vice President & Business Group Director at Rohm & Haas Co. and Manager at Shipley Co. LLC. Yi Hyon Paik received an undergraduate degree and a graduate degree from Seoul National University and a doctorate from the University of Pittsburgh.

Yi Sun currently works at Beijing Shougang Co., Ltd., as Chairman-Supervisory Board from 2021.

Yi Liu has founded iHealth Labs, Inc. in 2010.
Currently, Mr. Liu holds the position of Chairman at Andon Health Co., Ltd.
since 2007 and Chairman at Tianjin Beiyang Haitang Venture Investment Management Co. Ltd.

Presently, Yi Cao occupies the position of Chief Financial Officer & Joint Secretary at Weimob, Inc.

Yi Luo is on the board of Hoshine Silicon Industry Co., Ltd.

Currently, Yi Zhang is Chief Financial Officer for China Construction Bank Corp. Mr. Zhang received an undergraduate degree from Southwestern University of Finance & Economics and an MBA from Renmin University of China.